The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

9551–9575 of 11860

  • HighFDA (Drugs)·D-751-2015·2015-04-29

    Attix Pharmaceuticals Recalls Letrazole Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Letrazole active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Letrazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-615-2015·2015-04-29

    Attix Pharmaceuticals Recalls Daptomycin API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Daptomycin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Daptomycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-816-2015·2015-04-29

    Attix Pharmaceuticals Recalls Nevirapine API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Nevirapine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Nevirapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-519-2015·2015-04-29

    Attix Pharmaceuticals Recalls Ammonium Tetrathiomolybdate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Ammonium Tetrathiomolybdate active pharmaceutical ingredient due to potential penicillin cross-contamination from repackaging in a shared facility.

    Product
    Ammonium Tetrathiomolybdate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-616-2015·2015-04-29

    Attix Pharmaceuticals Recalls Darunavir API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Darunavir active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Darunavir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-863-2015·2015-04-29

    Attix Pharmaceuticals Recalls Procainamide HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Procainamide HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Procainamide HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-538-2015·2015-04-29

    Attix Pharmaceuticals Recalls Benoxinate HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Benoxinate HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Benoxinate HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-609-2015·2015-04-29

    Attix Pharmaceuticals Recalls Dacarbazine Due to Penicillin Cross Contamination Risk

    Attix Pharmaceuticals is recalling Dacarbazine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Dacarbazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-866-2015·2015-04-29

    Attix Pharmaceuticals Recalls Procarbazine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Procarbazine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Procarbazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-938-2015·2015-04-29

    Attix Pharmaceuticals Recalls Tranexamic Acid Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Tranexamic Acid active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Tranexamic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-679-2015·2015-04-29

    Flumazenil API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Flumazenil active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Flumazenil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-852-2015·2015-04-29

    Attix Pharmaceuticals Recalls Povidone K-30 Ingredient Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Povidone K-30 pharmaceutical ingredient lots distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Povidone K-30 pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-732-2015·2015-04-29

    Attix Pharmaceuticals Recalls Indocyanine Green Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Indocyanine Green active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Indocyanine Green active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-545-2015·2015-04-29

    Attix Pharmaceuticals Recalls Bismuth Subcarbonate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Bismuth Subcarbonate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Bismuth Subcarbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-585-2015·2015-04-29

    Attix Pharmaceuticals Recalls Cilostazol API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling cilostazol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Cilostazol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-524-2015·2015-04-29

    Attix Pharmaceuticals Recalls Artemether Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Artemether active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Artemether active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-652-2015·2015-04-29

    Attix Pharmaceuticals Recalls Estradiol Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Estradiol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Estradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-835-2015·2015-04-29

    Attix Pharmaceuticals Recalls Penciclovir Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling penciclovir active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Penciclovir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-502-2015·2015-04-29

    Adapalene API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling all lots of Adapalene active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Adapalene active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-769-2015·2015-04-29

    Attix Pharmaceuticals Recalls Loratadine API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Loratadine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Loratadine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-848-2015·2015-04-29

    Attix Pharmaceuticals Recalls Polidocanol Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Polidocanol (Industrial Grade) active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Polidocanol (Industrial Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-581-2015·2015-04-29

    Attix Pharmaceuticals Recalls Chlorpromazine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Chlorpromazine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Chlorpromazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-905-2015·2015-04-29

    Sucralfate API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling sucralfate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Sucralfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-644-2015·2015-04-29

    Attix Pharmaceuticals Recalls D-Penicillamine Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling D-Penicillamine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    D-Penicillamine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-522-2015·2015-04-29

    Attix Pharmaceuticals Recalls Anastrozole API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Anastrozole active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Anastrozole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide